DK1140203T3 - Farmaceutiske præparater som vitronectinreceptorantagonist - Google Patents
Farmaceutiske præparater som vitronectinreceptorantagonistInfo
- Publication number
- DK1140203T3 DK1140203T3 DK99967442T DK99967442T DK1140203T3 DK 1140203 T3 DK1140203 T3 DK 1140203T3 DK 99967442 T DK99967442 T DK 99967442T DK 99967442 T DK99967442 T DK 99967442T DK 1140203 T3 DK1140203 T3 DK 1140203T3
- Authority
- DK
- Denmark
- Prior art keywords
- novel compounds
- present
- contrast agent
- treatment
- provides novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4806—Details not adapted to a particular type of sample
- G01N25/4813—Details not adapted to a particular type of sample concerning the measuring means
- G01N25/482—Details not adapted to a particular type of sample concerning the measuring means concerning the temperature responsive elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
- G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
- B01J2219/00315—Microtiter plates
- B01J2219/00317—Microwell devices, i.e. having large numbers of wells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00495—Means for heating or cooling the reaction vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
- B01J2219/00707—Processes involving means for analysing and characterising the products separated from the reactor apparatus
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Combustion & Propulsion (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11282998P | 1998-12-18 | 1998-12-18 | |
PCT/US1999/030312 WO2000035488A2 (fr) | 1998-12-18 | 1999-12-17 | Medicaments antagonistes du recepteur de la vitronectine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1140203T3 true DK1140203T3 (da) | 2007-09-10 |
Family
ID=22346047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99967442T DK1140203T3 (da) | 1998-12-18 | 1999-12-17 | Farmaceutiske præparater som vitronectinreceptorantagonist |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1140203B1 (fr) |
AT (1) | ATE362772T1 (fr) |
AU (1) | AU2371500A (fr) |
CA (1) | CA2346935A1 (fr) |
DE (1) | DE69936148T2 (fr) |
DK (1) | DK1140203T3 (fr) |
ES (1) | ES2288040T3 (fr) |
PT (1) | PT1140203E (fr) |
TR (1) | TR200101775T2 (fr) |
WO (1) | WO2000035488A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6794518B1 (en) | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
EP1296678A2 (fr) * | 2000-06-21 | 2003-04-02 | Bristol-Myers Squibb Pharma Company | Produits pharmaceutiques d'antagonistes recepteurs de la vitronectine utilises en polytherapie |
TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
WO2003062198A1 (fr) | 2002-01-24 | 2003-07-31 | Barnes Jewish Hospital | Agents d'imagerie ciblant des integrines |
US7279150B2 (en) | 2002-01-24 | 2007-10-09 | Barnes-Jewish Hospital | Chelating agents with lipophilic carriers |
US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
GB0305422D0 (en) * | 2003-03-10 | 2003-04-16 | Univ Open | Detection, monitoring and treatment of cancer |
EP1622647B1 (fr) * | 2003-05-12 | 2009-11-25 | Lantheus Medical Imaging, Inc. | Composes de l antagoniste du recepteur de la vitronectine et leur utilisation dans la preparation de produits radio pharmaceutiques |
US7319149B2 (en) * | 2003-06-13 | 2008-01-15 | Bristol-Myers Squibb Pharma Company | Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
EP1768558A4 (fr) | 2004-06-09 | 2009-11-25 | Kereos Inc | Derives lipophiles de monoamides chelates |
WO2006004429A2 (fr) * | 2004-07-02 | 2006-01-12 | Ge Healthcare As | Agents d'imagerie avec profils pharmacocinetiques ameliores |
JP6215335B2 (ja) * | 2013-09-24 | 2017-10-18 | 富士フイルム株式会社 | 新規な含窒素化合物もしくはその塩またはそれらと金属との錯体 |
JP6286467B2 (ja) * | 2015-03-25 | 2018-02-28 | 富士フイルム株式会社 | インテグリンが関与する疾患の診断または治療の処置剤 |
MX2017012184A (es) * | 2015-03-25 | 2018-01-09 | Fujifilm Corp | Metodo para manufacturar compuesto novedoso que contiene nitrogeno o sal del mismo e intermediario de manufacturacion del compuesto novedoso que contiene nitrogeno o sal del mismo. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10504807A (ja) * | 1994-06-29 | 1998-05-12 | スミスクライン・ビーチャム・コーポレイション | ビトロネクチン受容体拮抗剤 |
GB9511989D0 (en) * | 1995-06-13 | 1995-08-09 | Glaxo Group Ltd | Chemical compounds |
RO118289B1 (ro) * | 1995-08-30 | 2003-04-30 | Gd Searle & Co Chicago | Derivati de fenilcarboniluree si compozitie farmaceutica |
AU1345697A (en) * | 1995-12-22 | 1997-07-17 | Du Pont Merck Pharmaceutical Company, The | Novel integrin receptor antagonists |
ZA978758B (en) * | 1996-10-02 | 1999-03-30 | Du Pont Merck Pharma | Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents |
AU4753997A (en) * | 1996-10-16 | 1998-05-11 | Burnham Institute, The | Magnetic resonance imaging of thrombi |
AU8689798A (en) * | 1997-08-04 | 1999-02-22 | Smithkline Beecham Corporation | Integrin receptor antagonists |
WO2000006169A1 (fr) * | 1998-07-29 | 2000-02-10 | Merck & Co., Inc. | Antagonistes des recepteurs de l'integrine |
-
1999
- 1999-12-17 WO PCT/US1999/030312 patent/WO2000035488A2/fr active IP Right Grant
- 1999-12-17 DK DK99967442T patent/DK1140203T3/da active
- 1999-12-17 TR TR2001/01775T patent/TR200101775T2/xx unknown
- 1999-12-17 AT AT99967442T patent/ATE362772T1/de not_active IP Right Cessation
- 1999-12-17 EP EP99967442A patent/EP1140203B1/fr not_active Expired - Lifetime
- 1999-12-17 AU AU23715/00A patent/AU2371500A/en not_active Abandoned
- 1999-12-17 DE DE69936148T patent/DE69936148T2/de not_active Expired - Fee Related
- 1999-12-17 CA CA002346935A patent/CA2346935A1/fr not_active Abandoned
- 1999-12-17 ES ES99967442T patent/ES2288040T3/es not_active Expired - Lifetime
- 1999-12-17 PT PT99967442T patent/PT1140203E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
AU2371500A (en) | 2000-07-03 |
WO2000035488A3 (fr) | 2000-11-09 |
DE69936148D1 (de) | 2007-07-05 |
WO2000035488A2 (fr) | 2000-06-22 |
EP1140203A2 (fr) | 2001-10-10 |
ES2288040T3 (es) | 2007-12-16 |
CA2346935A1 (fr) | 2000-06-22 |
PT1140203E (pt) | 2007-08-30 |
EP1140203B1 (fr) | 2007-05-23 |
ATE362772T1 (de) | 2007-06-15 |
DE69936148T2 (de) | 2008-01-24 |
TR200101775T2 (tr) | 2002-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000035492A3 (fr) | Medicaments antagonistes du recepteur de la vitronectine | |
WO1999058162A3 (fr) | Produits pharmaceutiques pour l'imagerie de troubles angiogenes | |
WO2000035887A3 (fr) | Medicaments antagonistes du recepteur de la vitronectine | |
DK1140203T3 (da) | Farmaceutiske præparater som vitronectinreceptorantagonist | |
WO2001098294A3 (fr) | Produits pharmaceutiques d'antagonistes recepteurs de la vitronectine utilises en polytherapie | |
WO2001097861A3 (fr) | Agents pharmaceutiques antagonistes du recepteur de la vitronectine destines a etre utilises dans une therapie combinee | |
O'Connell et al. | Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET | |
WO2001097860A3 (fr) | Produits pharmaceutiques pour l'imagerie de troubles angiogeniques | |
NO20031323D0 (no) | Peptid-baserte forbindelser | |
Nedrow et al. | Targeting PSMA with a Cu-64 labeled phosphoramidate inhibitor for PET/CT imaging of variant PSMA-expressing xenografts in mouse models of prostate cancer | |
Pandey et al. | Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I-labeled methyl-3-(1′-iodobenzyloxyethyl) pyropheophorbide-a vs the corresponding glucose and galactose conjugates | |
DE60136632D1 (de) | Vitronectin rezeptor antagonist pharmaka | |
Carpenter et al. | Halogenated Benzimidazole Carboxamides Target Integrin α4β1 on T-Cell and B-Cell Lymphomas | |
ES2114570T3 (es) | Utilizacion de derivados de prostaciclina para la inhibicion o el tratamiento de trastornos de la microcirculacion en el caso de la toma de agentes de contraste por rayos x, resonancia magnetica nuclear o ultrasonidos. | |
JP2019043892A (ja) | オリゴペプチド誘導体およびそれを用いた医薬 | |
DK0759785T3 (da) | Liposomsuspensioner som blodkontrastmidler | |
DE60033697D1 (de) | Radiomarkierte vip-analoge zur diagnose und therapie | |
AR023069A1 (es) | Productos farmaceuticos antagonistas del receptor de vitronectina | |
Wang et al. | Synthesis and evaluation of a radioiodinated benzothiazole derivative as a radioligand for in vivo quantitation of β‐amyloid deposits in aging and alzheimer's disease | |
Lekakis et al. | Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging | |
Roivainen et al. | In Vivo Imaging of Inflammation | |
KR20230022470A (ko) | 방사성 동위원소가 표지된 바이오틴 유도체 화합물 및 이를 유효성분으로 포함하는 암 진단용 조성물 | |
Molea et al. | Biodistribution pharmacokinetics and dosimetry of 99m Tc-D-glucaric acid in humans | |
Dopamine | PET and Pediatric Hodgkin’s Relapse | |
Meredith et al. | Radioimmunotherapy for metastatic prostate cancer using a high affinity antibody |